Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for KalVista Pharmaceuticals (KALV) over the last 8 years, with Q2 2025 value amounting to $3.4 million.

  • KalVista Pharmaceuticals' Exchange Rate Effect rose 464594.59% to $3.4 million in Q2 2025 from the same period last year, while for Apr 2025 it was $3.8 million, marking a year-over-year increase of 41442.7%. This contributed to the annual value of $2.6 million for FY2025, which is 31755.98% up from last year.
  • According to the latest figures from Q2 2025, KalVista Pharmaceuticals' Exchange Rate Effect is $3.4 million, which was up 464594.59% from $407000.0 recorded in Q4 2024.
  • KalVista Pharmaceuticals' Exchange Rate Effect's 5-year high stood at $3.4 million during Q2 2025, with a 5-year trough of -$621000.0 in Q1 2024.
  • Over the past 3 years, KalVista Pharmaceuticals' median Exchange Rate Effect value was $84000.0 (recorded in 2023), while the average stood at $382142.9.
  • Per our database at Business Quant, KalVista Pharmaceuticals' Exchange Rate Effect soared by 3928.57% in 2024 and then surged by 464594.59% in 2025.
  • KalVista Pharmaceuticals' Exchange Rate Effect (Quarter) stood at -$602000.0 in 2023, then soared by 167.61% to $407000.0 in 2024, then surged by 726.54% to $3.4 million in 2025.
  • Its Exchange Rate Effect was $3.4 million in Q2 2025, compared to $407000.0 in Q4 2024 and $117000.0 in Q3 2024.